| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | - | 0 | 8.548 | 101.769 | 163.962 | 158.494 |
| Total Expenses - EUR | - | - | - | - | - | 22 | 391.230 | 490.411 | 223.136 | 216.495 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -22 | -382.682 | -388.642 | -59.175 | -58.001 |
| Net Profit/Loss - EUR | - | - | - | - | - | -22 | -382.939 | -391.695 | -59.175 | -58.001 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Polipharma Distributie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 5.288.293 | 7.491.911 | 7.616.924 | 7.757.787 | 7.872.925 |
| Current Assets | - | - | - | - | - | 10.337 | 10.209 | 2.418 | 1.250 | 499 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | - | 10.337 | 10.209 | 2.418 | 1.250 | 499 |
| Shareholders Funds | - | - | - | - | - | 10.315 | -339.498 | -732.246 | -789.200 | -842.790 |
| Social Capital | - | - | - | - | - | 10.337 | 43.462 | 43.597 | 43.465 | 43.222 |
| Debts | - | - | - | - | - | 5.288.315 | 7.841.618 | 8.351.588 | 8.548.238 | 8.716.214 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Polipharma Distributie S.r.l.